US EPA

5081172 

Journal Article 

Prenatal perfluorooctanoic acid exposure and glutathione s-transferase T1/M1 genotypes and their association with atopic dermatitis at 2 years of age 

Wen, HJ; Wang, SL; Chen, PC; Guo, YL 

2019 

1 

PLoS ONE
EISSN: 1932-6203 

PUBLIC LIBRARY SCIENCE 

SAN FRANCISCO 

14 

1 

e0210708 

English 

30650146 

10.1371/journal.pone.0210708 

WOS:000455813300071 

https://www.proquest.com/docview/2167792402?accountid=171501&bdid=35852&_bd=GXU9V3%2BEhuX6OEME6Gl%2FM%2BWW5%2Fc%3D
Exit
 

BACKGROUND: Perfluoroalkyl substance (PFAS) exposure was found associated with atopic diseases. Atopic dermatitis (AD) is a childhood skin disorder. However, the effect of interaction between PFASs and glutathione S-transferase (GST) T1/M1 genotype on AD remains unclear.

OBJECTIVE: To investigate the association between gene-environmental interaction and childhood AD using a birth cohort study.

METHODS: From 2001 to 2005, 1,264 mother-newborn pairs were recruited from eight Taiwanese maternity hospitals. PFAS levels and Genotypes were analysed from cord blood. Information on children's health status including AD occurrence was obtained via phone interviews at 6 months and 2 years. Cord plasma concentrations of nine PFASs were measured via ultra-high performance liquid chromatography/tandem mass spectrometry. GSTT1/M1 was genotyped (null/present) via polymerase chain reaction. Environment-gene interaction effects on AD were assessed using multiple logistic regression analysis.

RESULTS: Overall, 839 mother-newborn pairs completed all measurements. The prevalence of ever having physician-diagnosed AD by 2 years of age was 5.4%. Among PFASs, perfluorooctanoic acid (PFOA) was positively associated with AD adjusted for potential confounders. After grouping PFOA levels into three groups: undetected, below and above the median in those with detected, children in above the median group who had the GSTT1-null, or GSTM1-null genotype exhibited a higher odds ratio for AD (OR [95%CI] = 3.45 [1.26-9.99] and 2.92 [1.12-7.91], respectively) as compared to the undetected group.

CONCLUSIONS: Our data demonstrated that in-utero PFOA exposure with GSTT1/M1 null genotype were associated with AD. Minimizing early-life PFAS exposure may help against AD development, especially in genetically susceptible individuals.